Latest Options News

LTR Pharma has partnered with Strategic Drug Solutions to co-develop OROFLOW®, a novel intranasal spray aimed at providing fast symptom relief for Oesophageal Motility Disorders, tapping into a growing $4.5 billion global market.

James Bay Minerals has significantly increased its land position adjacent to its Independence Gold Project in Nevada, enhancing its exploration and development potential in a prolific mining district.

ANZ Group Holdings Limited has announced its 2025 interim dividend of 83 cents per share, partially franked and accompanied by New Zealand imputation credits. The bank’s Dividend Reinvestment Plan and Bonus Option Plan will continue without discount, underscoring steady shareholder returns.

ANZ Group Holdings Limited has announced an interim dividend of 83 cents per share, partially franked at 70%, payable on 1 July 2025, with options for shareholders to receive payments in AUD, NZD, or GBP.

Nexus Minerals Limited has updated its exploration progress with significant gold resources at Wallbrook and Pinnacles projects, alongside promising new discoveries and ongoing drilling campaigns.

Tivan Limited has locked in a $5 million share placement and signed a non-binding term sheet for a $51.3 million equity investment to fund the Speewah Fluorite Project, marking a significant step in its development plans.

Santana Minerals reports promising assay results from recent drilling at its Rise and Shine deposit, revealing extensions of high-grade gold mineralisation beyond current resource boundaries. These findings hint at significant upside potential for the project’s resource base.

Western Yilgarn Limited has successfully closed its non-renounceable Entitlement and Priority Option Offers, raising nearly A$54,000 through the issue of new options to shareholders.

Terra Metals has exercised its option to acquire HRM Exploration, significantly expanding its Dante Project tenure in Western Australia’s West Musgrave region. The all-scrip deal positions Terra to accelerate exploration in a mineral-rich province analogous to South Africa’s Bushveld.

Acrux Limited has appointed John Warmbrunn as its new CEO and Managing Director, signaling a strategic push for international expansion and product development starting June 2025.

LCL Resources has renegotiated its sale option agreement with Tiger Gold Corp, increasing the total consideration to $14 million and removing the 'Stay Private' clause. The revised terms will be presented for shareholder approval at the upcoming AGM.

CLINUVEL Pharmaceuticals has completed recruitment for its Phase III trial of SCENESSE® in vitiligo patients with darker skin types, setting the stage for first results in late 2026. Early clinical observations suggest promising repigmentation outcomes.